Amanda
Fenster

Prior to rejoining Cravath, Ms. Fenster’s notable matters include representing:

• Yum! Brands in its $2.7 billion sale of Pizza Hut to LongRange Capital and Yum China Holdings 
• Six Flags Entertainment in its $331 million sale of Seven Parks to EPR Properties 
• Harbour Energy in its $3.2 billion acquisition of LLOG Exploration 
• Dun & Bradstreet in its $7.7 billion sale to Clearlake Capital Group 
• Willis Towers Watson in its $632 million sale of TRANZACT to GTCR and Recognize and in its proposed $80 billion combination with Aon 
• ChampionX in its approximately $7.8 billion sale to SLB 
• Sanofi in its approximately $2.2 billion acquisition of Inhibrx and its $2.5 billion acquisition of Synthorx 
• Covetrus in its $4 billion sale to CD&R, a holder of approximately 24% of Covetrus’ outstanding common stock, and TPG 
• WEX Health (a subsidiary of WEX) in its $180 million acquisition of an Ascensus Health & Benefits line of business from Ascensus 
• Quest Diagnostics in its acquisitions of Haystack Oncology, Blueprint Genetics and the U.S. laboratory services business of Oxford Immunotec Global 
• Churchill Capital Corp III, a SPAC sponsored by Churchill Capital Group, in its $5.7 billion merger with MultiPlan that implied an enterprise value based on the transaction of approximately $11 billion 
• CoStar Group in numerous transactions, including in its $450 million acquisition of STR and its acquisitions of Cozy Services, Off Campus Partners and Ten‑X 
• AK Steel in its $3 billion sale to Cleveland‑Cliffs 
• Brookfield Asset Management in its approximately $4.8 billion acquisition of a 61.2% stake in Oaktree Capital Group 
• Eli Lilly and Company in the separation and initial public offering of Elanco Animal Health and Eli Lilly’s $8.2 billion offer to exchange Elanco common stock for Eli Lilly common stock, completing the separation of Elanco from Eli Lilly 
• General Electric in its $2.6 billion sale of GE Industrial Solutions to ABB 
• Ontario Teachers’ Pension Plan in its acquisition of a majority stake in NVISION; together with Apollo Global Management, the acquisition of a controlling interest in CareerBuilder; and together with L Catterton and others, the sale of PetVet Care Centers 
• Hologic in its $350 million acquisition of Gynesonics; its $795 million acquisition of Mobidiag; and its $159 million acquisition of Diagenode 
• 8 Rivers Capital in its $100 million sale of a minority stake to SK Group and the formation of a joint venture with SK focused on the decarbonization of Korean and key Asian markets 
• Luminar Technologies in its $110 million sale of Luminar Semiconductor to Quantum Computing and $33 million sale of LiDAR business to MicroVision 
• Superior Industries International in its sale to a group of its term loan investors, including Oaktree Capital Management

Ms. Fenster’s notable prior matters at Cravath include representing:

• MarkWest Energy Partners in its $21 billion merger with MPLX 
• Sapient in its $3.7 billion sale to Publicis Groupe 
• The Transaction Committee of the Board of Directors of Norwegian Cruise Line in the $3.025 billion acquisition of Prestige Cruises International by Norwegian 
• InterMune in its $8.9 billion sale to Roche 
• British American Tobacco in its $4.7 billion investment in Reynolds American as part of Reynolds American’s $27.6 billion purchase of Lorillard and sale to Imperial Tobacco of the KOOL, Salem, Winston, Maverick and blu eCigs brands and other assets and liabilities for total consideration of $7.1 billion 
• Graham Holdings in its $1.1 billion split‑off transaction of WPLG to Berkshire Hathaway 
• Zale in its $1.46 billion sale to Signet Jewelers and its related successful proxy fight with TIG Advisors
• Polymer Group in its $325 million sale to Blackstone
• IBM in its acquisitions of BigFix, Initiate Systems and Lombardi Software

Ms. Fenster has been featured among the “Top Women in Dealmaking” by The Deal and is a recipient of The M&A Advisor’s Emerging Leaders Award. She has been named by Lawdragon among the “500 Leading Dealmakers in America” and the “500 X - The Next Generation.” Ms. Fenster has been repeatedly recognized as a leading lawyer in the area of mergers and acquisitions by The Legal 500 US, IFLR1000 and Super Lawyers. She was also named a “Rising Star” for Mergers & Acquisitions by Law360, The Deal: Movers & Shakers, Expert Guides and Super Lawyers.

Ms. Fenster was born in New York, New York. She received a B.A. cum laude from the University of Pennsylvania in 2005 and a J.D. cum laude from the University of Pennsylvania Law School in 2009. Ms. Fenster began her career as an associate at Cravath. She left the Firm in 2015 to serve as Associate General Counsel at IDEXX Laboratories, then practiced at another law firm in New York before rejoining Cravath as a partner in 2026.